Pectasides, D., Dafni, U., Aravantinos, G., Timotheadou, E., Skarlos, D.V., Pavlidis, N., … Fountzilas, G. (2007). A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin. Anticancer Research, 27(6C), 4411–4417.
To compare oral ondansetron to oral dissolving tablet (ODT) ondansetron at the same dose (8 mg twice daily for three days)
This was a phase II, randomized trial.